MSMiriam Scadeng

Miriam Scadeng

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Miriam Scadeng has a total of 12 co-authors. Here are the top co-authors by number of shared publications:

  • Alexandra K. Dvornikova

    Department of Neurology, University of California, Irvine, CA, USA

    1 shared publication
  • Annlia Paganini-Hill

    Beckman Laser Institute and Medical Clinic, University of California-Irvine School of Medicine, Irvine, CA, USA

    1 shared publication
  • David H. Cribbs

    Institute for Memory Impairments and Neurological Disorders, University of California, Irvine, CA, USA

    1 shared publication
  • David J. Dubowitz

    From the *Department of Radiology, Center for Functional Magnetic Resonance Imaging, and ‡Division of Physiology, Department of Medicine, University of California, San Diego, La Jolla, California; and †Institute of Membrane and Systems Biology, Centre of Sport and Exercise Sciences, University of Leeds, Leeds, United Kingdom

    1 shared publication
  • Ellen C. Breen

    Department of Medicine, University of California, San Diego, La Jolla, California

    1 shared publication
  • Harry B. Rossiter

    Respiratory Research Center The Lundquist Institute for Biomedical Innovation at Harbor‐UCLA Medical Center Torrance California USA

    1 shared publication

Latest Publications

  • Open Access

    A murine model of inflammation-induced cerebral microbleeds

    by Rachita K. Sumbria, Mher Mahoney Grigoryan, Vitaly Vasilevko, Tatiana B. Krasieva, Miriam Scadeng, Alexandra K. Dvornikova, Annlia Paganini-Hill, Ronald Kim, David H. Cribbs, Mark J. Fisher

    Cerebral microhemorrhages (CMH) are tiny deposits of blood degradation products in the brain and are pathological substrates of cerebral microbleeds. The existing CMH animal models are β-amyloid-, hypoxic brain injury-, or hypertension-induced. Recent evidence shows that CMH develop independently of hypoxic brain injury, hypertension, or amyloid deposition and CMH are associated with normal aging, sepsis, and neurodegenerative conditions. One common factor among the above pathologies is inflammation, and recent clinical studies show a link between systemic inflammation and CMH. Hence, we hypothesize that inflammation induces CMH development and thus, lipopolysaccharide (LPS)-induced CMH may be an appropriate model to study cerebral microbleeds. Adult C57BL/6 mice were injected with LPS (3 or 1 mg/kg, i.p.) or saline at 0, 6, and 24 h. At 2 or 7 days after the first injection, brains were harvested. Hematoxylin and eosin (H&E) and Prussian blue (PB) were used to stain fresh (acute) hemorrhages and hemosiderin (sub-acute) hemorrhages, respectively. Brain tissue ICAM-1, IgG, Iba1, and GFAP immunohistochemistry were used to examine endothelium activation, blood-brain barrier (BBB) disruption, and neuroinflammation. MRI and fluorescence microscopy were used to further confirm CMH development in this model. LPS-treated mice developed H&E-positive (at 2 days) and PB-positive (at 7 days) CMH. No surface and negligible H&E-positive CMH were observed in saline-treated mice (n = 12). LPS (3 mg/kg; n = 10) produced significantly higher number, size, and area of H&E-positive CMH at 2 days. LPS (1 mg/kg; n = 9) produced robust development of PB-positive CMH at 7 days, with significantly higher number and area compared with saline (n = 9)-treated mice. CMH showed the highest distribution in the cerebellum followed by the sub-cortex and cortex. LPS-induced CMH were predominantly adjacent to cerebral capillaries, and CMH load was associated with indices of brain endothelium activation, BBB disruption, and neuroinflammation. Fluorescence microscopy confirmed the extravasation of red blood cells into the brain parenchyma, and MRI demonstrated the presence of cerebral microbleeds. LPS produced rapid and robust development of H&E-positive (at 2 days) and PB-positive (at 7 days) CMH. The ease of development of both H&E- and PB-positive CMH makes the LPS-induced mouse model suitable to study inflammation-induced CMH.


  • High-Resolution Three-Dimensional Magnetic Resonance Imaging of Mouse Lung In Situ

    by Miriam Scadeng, Harry B. Rossiter, David J. Dubowitz, Ellen C. Breen

    Objectives: This study establishes a method for high-resolution isotropic magnetic resonance (MR) imaging of mouse lungs using tracheal liquid-instillation to remove MR susceptibility artifacts. Methods: C57BL/6J mice were instilled sequentially with perfluorocarbon and phosphate-buffered saline to an airway pressure of 10, 20, or 30 cm H2O. Imaging was performed in a 7T MR scanner using a 2.5-cm Quadrature volume coil and a 3-dimensional (3D) FLASH imaging sequence. Results: Liquid-instillation removed magnetic susceptibility artifacts and allowed lung structure to be viewed at an isotropic resolution of 78–90 μm3. Instilled liquid and modeled lung volumes were well correlated (R2 = 0.92; P < 0.05) and differed by a constant tissue volume (220 ± 92 μL). 3D image renderings allowed differences in structural dimensions (volumes and areas) to be accurately measured at each inflation pressure. Conclusion: These data demonstrate the efficacy of pulmonary liquid instillation for in situ high-resolution MR imaging of mouse lungs for accurate measurement of pulmonary airway, parenchymal, and vascular structures.